Society for Clinical Research Sites Announces ICON as New Global Impact Partner
Published on:
Applied Clinical Trials
The Society for Clinical Research Sites (SCRS), the global trade organization representing the interests of clinical research sites, announced a two-year relationship with ICON, a global provider of outsourced development services to the pharmaceutical, biotechnology and medical device industries. ICON will participate as a Global Impact Partner (GIP) and align with 31 other sponsors, CROs, and service providers dedicated to promoting high-level communication and meaningful collaboration between industry stakeholders and clinical research sites globally.
As a GIP, ICON will participate on the SCRS Global Impact Board at an executive level, and work closely with SCRS’ Leadership Council to determine strategic initiatives for SCRS.
